Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

ARS Pharmaceuticals, Inc.

GridBrain

GridBrain Sign in

GridSentinel

GridSentinel Sign in

GridAegis

GridAegis Sign in

Key Metrics

Market Snapshot

About

ARS Pharmaceuticals is a biopharmaceutical company developing treatments for severe allergic reactions. The company is advancing neffy, an investigational needle-free nasal epinephrine spray designed as an alternative to auto-injectors for the emergency treatment of Type I allergic reactions including anaphylaxis.